Benjamin Harshbarger
CIK 1653133 · Chief Legal Officer · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
24
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Chief Legal Officer | — | $12.58 | — | $0 | 5 | 2026-01-23 |
| Astria Therapeutics, Inc. (CATB) Delisted | Chief Legal Officer | — | $8.54 | — | $0 | 3 | 2021-06-10 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | See Remarks | 3,683 | — | — | $0 | 10 | 2019-05-13 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | General Counsel and Secretary | 0 | — | — | $0 | 5 | 2016-11-30 |
Recent Filings · Page 2 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-03 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Tax (F) | −52 | -$182 | EDGAR |
| 2018-02-14 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-10 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-19 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Mixed | +228 | -$772 | EDGAR |
| 2017-05-17 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Mixed | +485 | -$2.1K | EDGAR |
| 2017-05-11 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Mixed | +490 | -$2.2K | EDGAR |
| 2017-04-04 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Mixed | +121 | -$612 | EDGAR |
| 2016-12-27 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-01 | — | Grant (A) | +1,747 | $0 | |
| 2016-11-30 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Disp (D) | −1,704 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.